Answer
Infusion-related reactions, predominantly flushing and nausea, have been observed with intravenous voriconazole; stopping treatment should be considered depending on symptom severity.
Sources for this answer
- VFEND 200 mg powder for solution for infusionPfizer Limited · emc · SmPC §4.4 Special warnings and precautions for use · Version 68Document updated
Sources checked